Back
to sessions
Sep 28
Scientific
MODERATOR(S)
Kenneth Rosenzweig, MD, FASTRO - Icahn School of Medicine at Mount Sinai
Farzan Siddiqui, MD, PhD, MBA, FASTRO - Henry Ford Hospital/Wayne State University
Credits
| AMA PRA Category 1 Credits: | 1.50 |
Presentations
-
01:30pm - 01:40pm ET
Hypofractionated vs. Conventional Fractionated Postmastectomy Radiotherapy in High-Risk Breast Cancer: 10-Year Outcomes from a Phase 3 Randomized Trial
Speaker: Guang-Yi Sun, MD - National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical, Beijing -
01:40pm - 01:50pm ET
Initial Results of NRG Oncology NRG-GI003: A Phase III Randomized Trial of Protons vs. Photons for Hepatocellular Carcinoma (HCC)
Speaker: Theodore Hong, MD - Dana-Farber Cancer Institute, Boston -
01:50pm - 02:00pm ET
Alliance A071801 Phase III Trial Postoperative Single Fraction Stereotactic Radiosurgery (SRS) vs. Fractionated SRS (fSRS) for Resected Brain Metastasis
Speaker: Ayal Aizer, MD - Brigham and Women's Hospital, Boston -
02:00pm - 02:10pm ET
NRG-CC009: A Phase III Trial of Stereotactic Radiosurgery (SRS) vs. Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Brain Metastases from Small Cell Lung Cancer (SCLC)
Speaker: Chad Rusthoven, MD - University of Colorado School of Medicine, Aurora